Chromosomal aberrations in multiple myeloma: A study on Indian population

Chromosomal aberrations in multiple myeloma: A study on Indian population

Aims: The aim of this study was to evaluate the complexity of the chromosomal abnormalities in multiple myeloma (MM) cases and to correlate the findings with the previous reported cases. Materials and Methods: Bone marrow samples were obtained from patients with MM and sent for cytogenetic study. Th...

Full description

Bibliographic Details
Main Authors:	Angel Beula P. Royal, Syeda Sabiha S. Lubna, P Beaulah Angel, Vijaya V Mysorekar, T S Sundareshan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Acta Medica International
Subjects:	Chromosomal aberrations in multiple myeloma cytogenetic markers in multiple myeloma multiple myeloma
Online Access:	http://www.actamedicainternational.com/article.asp?issn=2349-0578;year=2018;volume=5;issue=2;spage=74;epage=78;aulast=Royal

Similar Items

Conventional Cytogenetic Abnormalities in Plasma Cell Myeloma and Their Prognostic Effect: A Single Center Experience in the Middle East
by: Moeinadin Safavi, et al.
Published: (2021-04-01)

Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context
by: P. Segges, et al.
Published: (2016-01-01)

A cytogenetic and epigenetic study on multiple myeloma in Chinese.
Published: (2003)

Multiple myelomda kromozomal aberasyonlar: klinik sonuçlar ve bortezomib’ e yanıt
by: Arbil AÇIKALIN, et al.
Published: (2019-06-01)

Multiple Myeloma: Heterogeneous in Every Way
by: Anaïs Schavgoulidze, et al.
Published: (2021-03-01)

A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
by: Mariarosaria Sessa, et al.
Published: (2020-12-01)

Progress in the identification of gene mutations involved in multiple myeloma
by: Hu Y, et al.
Published: (2019-05-01)

Molecular genetic studies of Chinese multiple myeloma.
Published: (2005)

Chromosome 13q14 deletions in Multiple Myeloma at Chris-Hani Baragwanath Hospital
by: Pheeha, Sekgokwa Teboho Stella
Published: (2010)

DIFFUSE REFLECTION ELECTRON SPECTROSCOPY IN STUDY OF BLOOD SERUM WITH MULTIPLE MYELOMA
by: Liudmila V. Plotnikova, et al.
Published: (2020-04-01)

High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
by: Maryam Pourabdollah, et al.
Published: (2016-11-01)

Introduction to the special section on multiple myeloma
by: Chang, C.Y, et al.
Published: (2022)

DNA methylation studies in multiple myeloma.
Published: (2004)

Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma
by: Yuto Fujibayashi, et al.
Published: (2020-08-01)

Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
by: Samer Al Hadidi, et al.
Published: (2017-03-01)

The Occurence of multiple myeloma at Dr George Mukhari Hospital, Gauteng: a retrospective review (2004-2009)
by: Rankapole, Ruth Khutso
Published: (2013)

Evaluation of the UK Myeloma Research Alliance Risk Profile in Chinese Patients with Newly Diagnosed Multiple Myeloma without Autologous Stem Cell Transplantation
by: Ma K, et al.
Published: (2021-04-01)

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
by: Massimo Martino, et al.
Published: (2021-05-01)

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
by: Massimo Offidani, et al.
Published: (2021-02-01)

Lenalidomide with dexamethasone to multiple myeloma patients relapsing from bortezomib-based induction therapies: A prospective, observational study
by: Tran-Der Tan, et al.
Published: (2020-01-01)

Testing Mayo Clinic’s New 20/20/20 Risk Model in Another Cohort of Smoldering Myeloma Patients: A Retrospective Study
by: Camille Tessier, et al.
Published: (2021-05-01)

Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy
by: Dima D, et al.
Published: (2020-08-01)

Game of Bones: How Myeloma Manipulates Its Microenvironment
by: Tyler Moser-Katz, et al.
Published: (2021-02-01)

Pseudohypercalcemia in Multiple Myeloma: A Case Report
by: Farzaneh Ashrafi, et al.
Published: (2016-07-01)

How we manage smoldering multiple myeloma
by: Alessandra Romano, et al.
Published: (2020-09-01)

Risk and Response-Adapted Treatment in Multiple Myeloma
by: Titouan Cazaubiel, et al.
Published: (2020-11-01)

Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
by: Katja Weisel, et al.
Published: (2020-08-01)

Association of Acromegaly and Multiple Myeloma: A Case Report
by: Murat Atmaca, et al.
Published: (2013-09-01)

Efficacy of Lenalidomide plus Low-Dose Dexamethasone in Thai Patients with Relapsed and/or Refractory Multiple Myeloma
by: Chutima Kunacheewa, et al.
Published: (2021-04-01)

The frequency of polyneuropathy and comparison of laboratory parameters in patients with multiple myeloma
by: Abdullah Sakin, et al.
Published: (2015-12-01)

Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
by: Rios-Tamayo R, et al.
Published: (2017-08-01)

Multiple Myeloma: An Update
by: Khalil Al-Farsi
Published: (2013-01-01)

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
by: Blum A, et al.
Published: (2018-04-01)

Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma
by: T A Mitina, et al.
Published: (2010-07-01)

IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
by: E. A. Senkina, et al.
Published: (2014-07-01)

A Rare Presentation of Biclonal Gammopathy in Multiple Myeloma with Simultaneous Extramedullary Involvement: A Case Report
by: Pragnan Kancharla, et al.
Published: (2019-07-01)

Light Chain Myeloma induced Severe Hypertriglyceridemia
by: Shafeeque Rahman, et al.
Published: (2017-03-01)

MicroRNAs: New Players in Multiple Myeloma
by: Flavia ePichiorri, et al.
Published: (2011-05-01)

In-hospital rehabilitation in the treatment of multiple myeloma
by: Alicja Mińko, et al.
Published: (2021-08-01)

Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma
by: Mara N. Zeissig, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_8ithsmfrlupvhlbk2lilosa3o0